{"id":7526,"date":"2013-06-11T04:21:01","date_gmt":"2013-06-11T08:21:01","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=7526"},"modified":"2013-06-11T04:21:12","modified_gmt":"2013-06-11T08:21:12","slug":"echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526","title":{"rendered":"Echo Therapeutics Inc (NASDAQ:ECTE) submits pre submission package for the Symphony CGM system"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 06\/11\/2013 (wallstreetpr) &#8211;\u00a0The shares of Echo Therapeutics Inc (NASDAQ:ECTE) had declined by 25.79 percent to close at $3.97 per share for the end of last trading session on Monday. The shares of the company had been trading in the range of $3.81 to $5.39 per share during the day. The shares of Echo Therapeutics Inc (NASDAQ:ECTE) had recorded\u00a0 52 week low price level of $0.53 per share and 52 week high price level of $19.40 per share.<\/p>\n<p style=\"text-align: justify;\">Echo Therapeutics Inc (NASDAQ:ECTE) is primarily engaged in the manufacture, marketing and sales of transdermal medical devices. The principal product candidate of the company is Prelude SkinPrep System which is based on a technology to provide for painless and skin permeation which is processed through both needle free drug delivery and analyte extraction.<\/p>\n<p style=\"text-align: justify;\">Echo Therapeutics Inc (NASDAQ:ECTE) had recently submitted its pre submission package for the Symphony CGM system being developed by the company for approval and permission from the Food and Drug Administration of the United States for use in hospitals in critical care situations. This system is developed for providing needle free continuous glucose monitoring and administration system to the patients.\u00a0 In line with this pre submission package for approval, the company had also requested a meeting with the FDA to enable cooperative working on the clinical and regulatory approval of the product by the Food and Drug Administration.<\/p>\n<p style=\"text-align: justify;\">This pre submission package would prove to be a milestone in the path of Echo Therapeutics Inc (NASDAQ:ECTE) towards commercialization of the Symphony CGM system in the United States market, as the meeting would provide maximum input for the company\u2019s pivotal trials of the product.<\/p>\n<p style=\"text-align: justify;\">Echo Therapeutics Inc (NASDAQ:ECTE) presently holds 63.26 million shares outstanding in the market with an institutional ownership of 7 percent of its holdings. The average trading volume for the company is at 28,631 shares per day.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 06\/11\/2013 (wallstreetpr) &#8211;\u00a0The shares of Echo Therapeutics Inc (NASDAQ:ECTE) had declined by 25.79 percent to close at $3.97 per share for the end [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":7527,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[263],"tags":[2592,2593],"stock_ticker":[],"class_list":["post-7526","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology","tag-echo-therapeutics-inc-nasdaqecte","tag-nasdaqecte","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Echo Therapeutics Inc (NASDAQ:ECTE) submits pre submission package for the Symphony CGM system - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Echo Therapeutics Inc (NASDAQ:ECTE) submits pre submission package for the Symphony CGM system - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 06\/11\/2013 (wallstreetpr) &#8211;\u00a0The shares of Echo Therapeutics Inc (NASDAQ:ECTE) had declined by 25.79 percent to close at $3.97 per share for the end [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-06-11T08:21:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2013-06-11T08:21:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/diet_pills.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"Echo Therapeutics Inc (NASDAQ:ECTE) submits pre submission package for the Symphony CGM system\",\"datePublished\":\"2013-06-11T08:21:01+00:00\",\"dateModified\":\"2013-06-11T08:21:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526\"},\"wordCount\":321,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/diet_pills.jpg\",\"keywords\":[\"Echo Therapeutics Inc (NASDAQ:ECTE)\",\"NASDAQ:ECTE\"],\"articleSection\":[\"Technology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526\",\"name\":\"Echo Therapeutics Inc (NASDAQ:ECTE) submits pre submission package for the Symphony CGM system - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/diet_pills.jpg\",\"datePublished\":\"2013-06-11T08:21:01+00:00\",\"dateModified\":\"2013-06-11T08:21:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/diet_pills.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/diet_pills.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Echo Therapeutics Inc (NASDAQ:ECTE) submits pre submission package for the Symphony CGM system\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Echo Therapeutics Inc (NASDAQ:ECTE) submits pre submission package for the Symphony CGM system - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526","og_locale":"en_US","og_type":"article","og_title":"Echo Therapeutics Inc (NASDAQ:ECTE) submits pre submission package for the Symphony CGM system - Wall Street PR","og_description":"Boston, MA 06\/11\/2013 (wallstreetpr) &#8211;\u00a0The shares of Echo Therapeutics Inc (NASDAQ:ECTE) had declined by 25.79 percent to close at $3.97 per share for the end [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-06-11T08:21:01+00:00","article_modified_time":"2013-06-11T08:21:12+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/diet_pills.jpg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"Echo Therapeutics Inc (NASDAQ:ECTE) submits pre submission package for the Symphony CGM system","datePublished":"2013-06-11T08:21:01+00:00","dateModified":"2013-06-11T08:21:12+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526"},"wordCount":321,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/diet_pills.jpg","keywords":["Echo Therapeutics Inc (NASDAQ:ECTE)","NASDAQ:ECTE"],"articleSection":["Technology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526","url":"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526","name":"Echo Therapeutics Inc (NASDAQ:ECTE) submits pre submission package for the Symphony CGM system - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/diet_pills.jpg","datePublished":"2013-06-11T08:21:01+00:00","dateModified":"2013-06-11T08:21:12+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/diet_pills.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/diet_pills.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/echo-therapeutics-inc-nasdaqecte-submits-pre-submission-package-for-the-symphony-cgm-system-7526#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Echo Therapeutics Inc (NASDAQ:ECTE) submits pre submission package for the Symphony CGM system"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/7526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=7526"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/7526\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/7527"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=7526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=7526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=7526"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=7526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}